Jim Simons
BIOA

Jim Simons’s BioAmber Inc. BIOA Stock Holding History

Jim Simons’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-56,400
Closed -$239K – 3614
2016
Q3 		$239K Buy
+56,400
New +$208K ﹤0.01% 3021
2014
Q3 		– Sell
-40,000
Closed -$398K – 3070
2014
Q2 		$398K Sell
40,000
-62,602
-61% -$646K ﹤0.01% 2394
2014
Q1 		$1.17M Buy
+102,602
New +$1.22M ﹤0.01% 2007

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Jim Simons's BIOA Position: Q4 2016 in Review

Jim Simons sold out of BioAmber Inc. (BIOA) in Q4 2016, closing a stake of 56,400 shares — an estimated $239K sold.

Jim Simons first reported a position in BIOA in Q1 2014 and held it in 3 quarters. The position peaked at $1.17M in Q1 2014. 32 funds tracked by Wall St. Rank hold BIOA as of Q4 2016.

  • Jim Simons reported no remaining BioAmber Inc. position as of Q4 2016 after selling out during the quarter.
  • Jim Simons sold 56,400 BioAmber Inc. shares in Q4 2016, an estimated $239K.
  • Jim Simons first reported a position in BioAmber Inc. in Q1 2014 and held it in 3 quarters.
  • Jim Simons's BioAmber Inc. position peaked at $1.17M in Q1 2014.
  • 32 funds tracked by Wall St. Rank held BioAmber Inc. as of Q4 2016.

Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.